Article 2Information exchange related to the planning and forecast of the joint clinical assessments and joint scientific consultations#
1.
2.
3.The European Medicines Agency shall provide the HTA secretariat with available updates of the information referred to in paragraphs 1 and 2, identified together with the EHT Subgroup as relevant for the preparation of the report on emerging health technologies referred to in Article 22 of Regulation (EU) 2021/2282.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.